Premature Rupture of Membranes (PROM) Testing Market – 2032

Premature Rupture of Membranes (PROM) Testing Market - By Product Type (Ultrasound, Nitrazine Test, Ferning Test, Pooling Test), By End-use (Hospitals, Diagnostic Laboratories) – Global Forecast to 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market definitions

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; working

1.2.1&nbsp;&nbsp;&nbsp; Data collection

1.3&nbsp;&nbsp;&nbsp; Forecast calculations

1.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp; Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp; Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Premature rupture of membranes (PROM) testing industry 3600&nbsp;synopsis, 2018 - 2032

2.2&nbsp;&nbsp;&nbsp; Business trends

2.3&nbsp;&nbsp;&nbsp; Regional trends

2.4&nbsp;&nbsp;&nbsp; Product type trends

2.5&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;Premature Rupture of Membranes (PROM) Testing Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Growing prevalence of chronic diseases worldwide

3.2.1.2&nbsp;&nbsp;&nbsp; Rising technological advancements in nuclear imaging systems

3.2.1.3&nbsp;&nbsp;&nbsp; Rise in healthcare expenditure

3.2.1.4&nbsp;&nbsp;&nbsp; Favourable government initiatives

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High cost of the nuclear imaging devices

3.2.2.2&nbsp;&nbsp;&nbsp; Lack of skilled or trained personnel in the developing and underdeveloped region

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By product type

3.3.2&nbsp;&nbsp;&nbsp; By end-use

3.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Technology landscape

3.6&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6.1&nbsp;&nbsp;&nbsp; U.S.

3.6.2&nbsp;&nbsp;&nbsp; Europe

3.7&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Competitive dashboard, 2022

4.4&nbsp;&nbsp;&nbsp; Company market share analysis, 2022

4.5&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.6&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.7&nbsp;&nbsp;&nbsp; Strategic outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Premature Rupture of Membranes (PROM) Testing Market and Forecast, By Product Type (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by product type

5.2&nbsp;&nbsp;&nbsp; Nitrazine test

5.3&nbsp;&nbsp;&nbsp; Ferning test

5.4&nbsp;&nbsp;&nbsp; Pooling test

5.5&nbsp;&nbsp;&nbsp; Ultrasound

5.6&nbsp;&nbsp;&nbsp; Others

Chapter 6&nbsp;&nbsp;&nbsp;Premature Rupture of Membranes (PROM) Testing Market and Forecast, By End-use (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by end-use

6.2&nbsp;&nbsp;&nbsp; Hospitals

6.3&nbsp;&nbsp;&nbsp; Diagnostic laboratories

6.4&nbsp;&nbsp;&nbsp; Others

Chapter 7&nbsp;&nbsp;&nbsp;Premature Rupture of Membranes (PROM) Testing Market and Forecast, By Region (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by region

7.2&nbsp;&nbsp;&nbsp; North America

7.2.1&nbsp;&nbsp;&nbsp; U.S.

7.2.2&nbsp;&nbsp;&nbsp; Canada

7.3&nbsp;&nbsp;&nbsp; Europe

7.3.1&nbsp;&nbsp;&nbsp; Germany

7.3.2&nbsp;&nbsp;&nbsp; UK

7.3.3&nbsp;&nbsp;&nbsp; France

7.3.4&nbsp;&nbsp;&nbsp; Spain

7.3.5&nbsp;&nbsp;&nbsp; Italy

7.3.6&nbsp;&nbsp;&nbsp; Switzerland

7.3.7&nbsp;&nbsp;&nbsp; Netherlands

7.3.8&nbsp;&nbsp;&nbsp; Poland

7.3.9&nbsp;&nbsp;&nbsp; Sweden

7.4&nbsp;&nbsp;&nbsp; Asia Pacific

7.4.1&nbsp;&nbsp;&nbsp; China

7.4.2&nbsp;&nbsp;&nbsp; Japan

7.4.3&nbsp;&nbsp;&nbsp; India

7.4.4&nbsp;&nbsp;&nbsp; Australia

7.4.5&nbsp;&nbsp;&nbsp; South Korea

7.4.6&nbsp;&nbsp;&nbsp; New Zealand

7.4.7&nbsp;&nbsp;&nbsp; Indonesia

7.4.8&nbsp;&nbsp;&nbsp; Thailand

7.4.9&nbsp;&nbsp;&nbsp; Vietnam

7.5&nbsp;&nbsp;&nbsp; Latin America

7.5.1&nbsp;&nbsp;&nbsp; Brazil

7.5.2&nbsp;&nbsp;&nbsp; Mexico

7.5.3&nbsp;&nbsp;&nbsp; Argentina

7.5.4&nbsp;&nbsp;&nbsp; Colombia

7.5.5&nbsp;&nbsp;&nbsp; Chile

7.5.6&nbsp;&nbsp;&nbsp; Peru

7.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

7.6.1&nbsp;&nbsp;&nbsp; South Africa

7.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

7.6.3&nbsp;&nbsp;&nbsp; UAE

7.6.4&nbsp;&nbsp;&nbsp; Iran

Chapter 8&nbsp;&nbsp;&nbsp;Company Profiles

8.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

8.2&nbsp;&nbsp;&nbsp; QIAGEN

8.3&nbsp;&nbsp;&nbsp; Hologic, Inc.

8.4&nbsp;&nbsp;&nbsp; Medix Biochemica

8.5&nbsp;&nbsp;&nbsp; Biosynex

8.6&nbsp;&nbsp;&nbsp; Clinical Innovations LLC

8.7&nbsp;&nbsp;&nbsp; Sera Prognostics Inc.

8.8&nbsp;&nbsp;&nbsp; The Cooper Companies Inc.

8.9&nbsp;&nbsp;&nbsp; NX Prenatal Inc.

8.10&nbsp;&nbsp;&nbsp; IQ Products 
&nbsp; &nbsp;

Premature Rupture of Membranes PROM Testing Market

Get a free sample of this report